Livzon Pharmaceutical Group Inc
SZSE:000513
Livzon Pharmaceutical Group Inc
Cash from Financing Activities
Livzon Pharmaceutical Group Inc
Cash from Financing Activities Peer Comparison
Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors
Company | Cash from Financing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Livzon Pharmaceutical Group Inc
SZSE:000513
|
Cash from Financing Activities
-¥1.7B
|
CAGR 3-Years
-47%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
H
|
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
|
Cash from Financing Activities
-¥818.1m
|
CAGR 3-Years
8%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
|
Cash from Financing Activities
-¥789.1m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-41%
|
CAGR 10-Years
N/A
|
|
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
|
Cash from Financing Activities
-¥1.8B
|
CAGR 3-Years
-124%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-36%
|
|
Yunnan Baiyao Group Co Ltd
SZSE:000538
|
Cash from Financing Activities
-¥2.9B
|
CAGR 3-Years
1%
|
CAGR 5-Years
-22%
|
CAGR 10-Years
-25%
|
|
C
|
CSPC Innovation Pharmaceutical Co Ltd
SZSE:300765
|
Cash from Financing Activities
¥365.2m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Livzon Pharmaceutical Group Inc's Cash from Financing Activities?
Cash from Financing Activities
-1.7B
CNY
Based on the financial report for Dec 31, 2023, Livzon Pharmaceutical Group Inc's Cash from Financing Activities amounts to -1.7B CNY.
What is Livzon Pharmaceutical Group Inc's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 3Y
-47%
Over the last year, the Cash from Financing Activities growth was -130%. The average annual Cash from Financing Activities growth rates for Livzon Pharmaceutical Group Inc have been -47% over the past three years .